“Winning this award is a testament to our efforts in using AI to improve chronic disease management,” Dr. Xie said. “By ...

Investing.com -- Moody’s Ratings has affirmed Gilead Sciences, Inc. ’s A3 senior unsecured ratings while revising the company’s outlook to positive from stable, citing momentum in the pharmaceutical ...

Gilead Sciences (GILD) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some ...

Over 100 years of market history shows that the best stocks often have an RS Rating north of 80 as they launch their biggest ...

While Gilead Sciences previously ponied up hundreds of millions of dollars to resolve kickback allegations related to its HIV ...

This year’s Fierce Pharma Marketing Awards ceremony, which took place in Philadelphia on Wednesday night, saw several major ...

A federal judge in Pennsylvania rejected a former Gilead Sciences sales representative’s claims that the company paid ...

After months of uncertainty, the Trump administration confirmed that it will work with Gilead Sciences and The Global Fund to ...

Approved in June for people at high risk of HIV, Yeztugo was shown to be nearly 100% effective at preventing infection in large trials.

The European Commission has granted marketing authorization for Gilead Sciences' twice-yearly injection for preventing HIV ...

The FDA said it would start releasing rejection letters soon after they are provided to drugmakers, a victory for those who ...

Gilead Sciences Inc. stopped a whistleblower’s suit alleging that the company violated the False Claims Act by establishing sham speaker programs to give meals and vacations to high-volume prescribers ...